Bausch + Lomb has announced its plans to further expand its Surgical Business product portfolio in India. The development is in line with the company's strategy to extend and strengthen its presence in the growing ophthalmology surgical devices and instruments market in the country.

The recent acquisition of Synergetics USA will provide additional impetus to Bausch + Lomb's portfolio expansion plans in India.

"We are pleased to further reinforce our commitment of adding and delivering world-class, innovative surgical devices and instruments to serve the needs of our community and patients. The addition of Synergetics' product portfolio will further consolidate our presence in India's expanding sector of vitreoretinal surgery," said Mr Sanjay Bhutani, MD, India and SAARC, Bausch + Lomb India.

Bausch + Lomb plans to launch its state of art product VersaVIT 2.0 Vitrectomy System, along with all the instruments and accessories ranging from illumination probes, packs, laser probes, filters, cannulas and other instruments.

Bausch + Lomb offers world-class and technological most advanced surgical equipment for Cataract and Refractive surgeries through platforms like Stellaris Vision Enhancement System, Teneo 317 excimer laser and Victus femtosecond laser with latest technologies for procedures like SUPRACOR and Zyoptix.

"Synergetics' business completely aligns with our business, which will enable us to offer an even wider range of products across cataract, vitreoretinal and refractive surgeries," said Mr Premal Pandya, commercial director, Ophthalmology and Aesthetics, Bausch + Lomb India.